Merck KGaA (MKGAF)
183.00
+3.00
(+1.67%)
USD |
OTCM |
May 20, 15:59
Merck Market Cap: 79.56B for May 20, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 78.26B |
| May 16, 2024 | 79.35B |
| May 15, 2024 | 76.34B |
| May 14, 2024 | 75.13B |
| May 13, 2024 | 71.44B |
| May 10, 2024 | 73.19B |
| May 09, 2024 | 71.93B |
| May 08, 2024 | 71.80B |
| May 07, 2024 | 73.38B |
| May 06, 2024 | 70.76B |
| May 03, 2024 | 70.53B |
| May 02, 2024 | 70.43B |
| May 01, 2024 | 67.00B |
| April 30, 2024 | 70.00B |
| April 29, 2024 | 70.98B |
| April 26, 2024 | 68.29B |
| April 25, 2024 | 71.88B |
| April 24, 2024 | 68.85B |
| April 23, 2024 | 69.78B |
| April 22, 2024 | 67.83B |
| April 19, 2024 | 67.83B |
| April 18, 2024 | 69.02B |
| April 17, 2024 | 69.02B |
| April 16, 2024 | 70.60B |
| April 15, 2024 | 70.43B |
| Date | Value |
|---|---|
| April 12, 2024 | 71.09B |
| April 11, 2024 | 71.69B |
| April 10, 2024 | 70.22B |
| April 09, 2024 | 73.15B |
| April 08, 2024 | 70.70B |
| April 05, 2024 | 70.43B |
| April 04, 2024 | 73.52B |
| April 03, 2024 | 74.56B |
| April 02, 2024 | 73.59B |
| April 01, 2024 | 76.74B |
| March 28, 2024 | 76.87B |
| March 27, 2024 | 75.75B |
| March 26, 2024 | 74.98B |
| March 25, 2024 | 75.65B |
| March 22, 2024 | 74.45B |
| March 21, 2024 | 76.30B |
| March 20, 2024 | 73.12B |
| March 19, 2024 | 74.35B |
| March 18, 2024 | 74.13B |
| March 15, 2024 | 76.02B |
| March 14, 2024 | 75.43B |
| March 13, 2024 | 76.40B |
| March 12, 2024 | 76.52B |
| March 11, 2024 | 74.67B |
| March 08, 2024 | 74.78B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
36.06B
Minimum
Mar 18 2020
114.21B
Maximum
Dec 27 2021
72.01B
Average
73.61B
Median
Oct 31 2022
Market Cap Benchmarks
| Affimed NV | 79.11M |
| InflaRx NV | 90.68M |
| MorphoSys AG | 2.799B |
| BioNTech SE | 22.27B |
Market Cap Related Metrics
| PE Ratio | 26.05 |
| PS Ratio | 3.503 |
| Price to Book Value | 2.698 |
| Price to Free Cash Flow | 41.75 |
| Price | 183.00 |
| Earnings Yield | 3.84% |
| Operating PE Ratio | 20.53 |
| Normalized PE Ratio | 26.20 |